Home > Quotes > IBB

iShares NASDAQ Biotechnology Index Fund Stock Quote & Summary Data

IBB 
$275.23
*  
0.16
0.06%
Get IBB Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading IBB now
Exchange: NASDAQ

Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
ETF Details
Summary Quote ETF Detail Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
ETF NEWS
ETF Headlines Market Stream
FUNDAMENTALS
Short Interest Dividend History
 Save stocks for next time
Best Bid /Ask: N/A / N/A
1 Year Target:
Today's High/Low:  / 
Share Volume:
50 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today's trading to the average daily volume. N/A
Previous Close: $ 275.07
52 Week High /Low: $ 278.78 / $ 191.2903
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 5,380,746,500
Annualized dividend $ 1.5726
Ex Dividend Date Jun. 25, 2014
Dividend Payment Date Jul. 1, 2014
Current Yield 0.57 %
Beta 0
NASDAQ Official Open Price NASDAQ Official Opening Price: This process identifies the NASDAQ-specific opening prices for NASDAQ-listed issues. $ 276.19
Date of Open Price This field refers to the date the NASDAQ Official Open Price was disseminated for a given stock. It is possible that the date will not be from the current trading day; this indicates that the stock didn't trade on NASDAQ during the current trading day. The NASDAQ Official Open Price is updated only when the stock is traded on NASDAQ. Sep. 19, 2014
NASDAQ Official Close Price The NASDAQ Official Closing Price (NOCP) is a process for identifying the NASDAQ market-specific closing price for NASDAQ-listed issues. The NOCP replaces the NASDAQ market-specific closing price that was based solely on the last reported NASDAQ trade. Subject to review by NASDAQ MarketWatch, the NOCP will equal the normalized price of the last trade reported to NASDAQ�s proprietary trade reporting system�Automated Confirmation Transaction ServiceSM (ACTSM�with a last sale eligible sale condition modifier as of 4:00:02 p.m., US Eastern Time. "Normalizing" the NOCP means it will be adjusted to the nearest prevailing inside quote whenever the last sale is reported away from the inside market. Market participants, data distributors and investors will be provided with the NOCP for all NASDAQ Global Select MarketSM, NASDAQ Global MarketSM and NASDAQ Capital MarketSM securities. $ 275.23
Date of Close Price This field refers to the date the NOCP was disseminated for a given stock. It is possible that the date will not be from the prior day; this indicates that the stock didn't trade on NASDAQ on the prior day. The NOCP is updated only when the stock is traded on NASDAQ. Sep. 19, 2014
Community Sentiment

Intraday Chart

Description

The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology Index (the "Underlying Index"). The Underlying Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals which also meet other eligibility criteria determined by NASDAQ, including minimum market capitalization and liquidity requirements. The Fund generally invests at least 90% of its assets in securities of the Underlying Index and in depositary receipts representing securities of the Underlying Index.


Underlying Index NASDAQ Biotechnology Index
Management Fee 0.48
Asset Class Equity
Leverage 1

News for IBB

Top Holdings
CELG Celgene Corp 8.4%
AMGN Amgen Inc 7.68%
GILD Gilead Sciences 7.46%
BIIB Biogen Idec Inc 7.38%
ALXN Alexion Pharmaceuticals 6.55%
VRTX Vertex Pharmaceuticals Inc 4.86%
ILMN Illumina Inc 4%
MYL Mylan Inc 3.88%
REGN Regeneron Pharmaceuticals 3.4%
ENDP Endo Pharmaceuticals Holdings Inc 2.4%

Research Brokers before you trade

Want to trade FX?